Towards reproducible computational drug discovery
2020 · Journal of Cheminformatics · 187 citations
https://doi.org/10.1186/s13321-020-0408-x
C
Chanin Nantasenamat
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
218
Papers
7.7K
Citations
52
h-index
147
i10-index
Chanin Nantasenamat is an academic researcher from Snowflake Inc. (United States). The author has contributed to research in topics: Computational Drug Discovery Methods & Machine Learning in Bioinformatics & Synthesis and biological activity. The author has an h-index of 52, co-authored 186 publications.
ORCID: 0000-0003-1040-663XPapers by this author
worksHemopred: A Web Server for Predicting the Hemolytic Activity of Peptides
2017 · Future Medicinal Chemistry · 135 citations
https://doi.org/10.4155/fmc-2016-0188
Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives
2014 · European Journal of Medicinal Chemistry · 112 citations
https://doi.org/10.1016/j.ejmech.2014.07.024
Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies
2015 · European Journal of Medicinal Chemistry · 104 citations
https://doi.org/10.1016/j.ejmech.2015.09.001
StackDPPIV: A novel computational approach for accurate prediction of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides
2021 · Methods · 85 citations
https://doi.org/10.1016/j.ymeth.2021.12.001
THPep: A machine learning-based approach for predicting tumor homing peptides
2019 · Computational Biology and Chemistry · 84 citations
https://doi.org/10.1016/j.compbiolchem.2019.05.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat